Research funding and funders focused on genetic disorders.
The Lawrence and Isabel Barnett Drug Development Program (2023) funded by the ALS Association offers funding for investigators in industry or academia worldwide focused on
The Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research Grant from Pfizer supports researchers in the USA working on ATTR Amyloidosis. Applicants must be based at a research
The Translational Research Program from the Jeffrey Modell Foundation supports innovative, translational research projects on primary immunodeficiency with the potential to lead to clinical applications.
The Early Diagnostics Grants funded by the ALS Association support translation research worldwide on amyotrophic lateral sclerosis (ALS), specifically the identification of early diagnostic markers
The Milton Safenowitz Postdoctoral Fellowship Program (2023) funded by the ALS Association offers funding to postdoctoral fellows investigating amyotrophic lateral sclerosis (ALS). Priority will be
The Junior Investigator Global ATTR Amyloidosis Research ASPIRE from Pfizer supports early-career principal investigators worldwide (except for the USA) working on ATTR Amyloidosis. The grant
The 3rd and 4th year Clinical Fellowship from the Cystic Fibrosis Foundation supports (adult and pediatric) physicians who have completed at least two years of
The 5th year Clinical Fellowship from the Cystic Fibrosis Foundation supports (adult and pediatric) physicians who have completed at least 4 years of fellowship training
The 1st and 2nd year Clinical Fellowship from the Cystic Fibrosis Foundation supports first and second year clinical fellows to pursue training in cystic fibrosis-relevant
The Project Funding from the A-T Society supports researchers working in the UK on Ataxia-Telangiectasia (A-T). The funding provides full or partial cover for investigator-initiated
You can unsubscribe at any time.
